Literature DB >> 18523768

Is absolute quantification of dopaminergic neurotransmission studies with 123I SPECT ready for clinical use?

Habib Zaidi, Georges El Fakhri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18523768      PMCID： PMC3124701          DOI： 10.1007/s00259-008-0842-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  31 in total

1.  Efficient fully 3-D iterative SPECT reconstruction with Monte Carlo-based scatter compensation.

Authors:  Freek J Beekman; Hugo W A M de Jong; Sander van Geloven
Journal:  IEEE Trans Med Imaging       Date:  2002-08       Impact factor: 10.048

2.  Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT.

Authors:  Marine Soret; Pierre Malick Koulibaly; Jacques Darcourt; Sébastien Hapdey; Irène Buvat
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

3.  Noise properties of the EM algorithm: II. Monte Carlo simulations.

Authors:  D W Wilson; B M Tsui; H H Barrett
Journal:  Phys Med Biol       Date:  1994-05       Impact factor: 3.609

4.  Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging.

Authors:  Douglas J Wagenaar; Maciej Kapusta; Junqiang Li; Bradley E Patt
Journal:  Technol Cancer Res Treat       Date:  2006-08

Review 5.  Strategies for attenuation compensation in neurological PET studies.

Authors:  Habib Zaidi; Marie-Louise Montandon; Steve Meikle
Journal:  Neuroimage       Date:  2006-11-17       Impact factor: 6.556

6.  Influence of movement on FP-CIT SPECT quantification: a Monte Carlo based simulation.

Authors:  Walter Koch; Mona Mustafa; Christian Zach; Klaus Tatsch
Journal:  Nucl Med Commun       Date:  2007-08       Impact factor: 1.690

7.  SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.

Authors:  A Abi-Dargham; M S Gandelman; G A DeErausquin; Y Zea-Ponce; S S Zoghbi; R M Baldwin; M Laruelle; D S Charney; P B Hoffer; J L Neumeyer; R B Innis
Journal:  J Nucl Med       Date:  1996-07       Impact factor: 10.057

8.  Concentration recovery for SPECT CNS dopamine-receptor studies for monkeys.

Authors:  L Shao; J Billings; N Pfeiffer; H F Kung
Journal:  Med Phys       Date:  1994-05       Impact factor: 4.071

9.  Absolute activity quantitation in simultaneous 123I/99mTc brain SPECT.

Authors:  G El Fakhri; S C Moore; P Maksud; A Aurengo; M F Kijewski
Journal:  J Nucl Med       Date:  2001-02       Impact factor: 10.057

10.  SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

Authors:  M Laruelle; R M Baldwin; R T Malison; Y Zea-Ponce; S S Zoghbi; M S al-Tikriti; E H Sybirska; R C Zimmermann; G Wisniewski; J L Neumeyer
Journal:  Synapse       Date:  1993-04       Impact factor: 2.562
View more
  4 in total

1.  Objective evaluation of reconstruction methods for quantitative SPECT imaging in the absence of ground truth.

Authors:  Abhinav K Jha; Na Song; Brian Caffo; Eric C Frey
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-04-13

2.  Estimating ROI activity concentration with photon-processing and photon-counting SPECT imaging systems.

Authors:  Abhinav K Jha; Eric C Frey
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-04-13

3.  The Role of CT-Based Attenuation Correction and Collimator Blurring Correction in Striatal Spect Quantification.

Authors:  J M Warwick; S Rubow; M du Toit; E Beetge; P Carey; P Dupont
Journal:  Int J Mol Imaging       Date:  2011-04-06

4.  Attenuation and scatter correction in I-123 FP-CIT SPECT do not affect the clinical diagnosis of dopaminergic system neurodegeneration.

Authors:  Miho Akahoshi; Koichiro Abe; Yumiko Uchiyama; Mitsuru Momose; Kenji Fukushima; Kazuo Kitagawa; Shuji Sakai
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.